Mesoblast (MESO) Total Liabilities (2015 - 2025)

Mesoblast (MESO) has reported Total Liabilities for 11 consecutive years, with $207.6 million the latest figure, recorded in Q4 2025.

• Quarterly Total Liabilities rose 8.11% year-over-year to $207.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $207.6 million (up 8.11% YoY) and the FY2025 annual result came in at $187.2 million, down 0.82% from the prior year.
• Total Liabilities improved to $207.6 million in Q4 2025 per MESO's latest filing, from $187.2 million in the prior quarter.
• Over the last five years, Total Liabilities for MESO reached as high as $207.6 million in Q4 2025 and fell as low as $161.6 million in Q4 2023.
• A 5-year average of $172.8 million and a median of $167.6 million in 2023 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2021 — Total Liabilities dropped 11.37% — and 2024, when it rose 18.88%.
• Year by year, Total Liabilities stood at $168.9 million in 2021, then declined by 0.52% to $168.1 million in 2022, then fell by 3.87% to $161.6 million in 2023, then increased by 18.88% to $192.1 million in 2024, then grew by 8.11% to $207.6 million in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $207.6 million, $187.2 million, and $192.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.